🇺🇸 FDA
Pipeline program

Armodafinil

C10953/2032/DP/US

Phase 2 small_molecule completed

Quick answer

Armodafinil for Bipolar I Depression is a Phase 2 program (small_molecule) at TEVA PHARMACEUTICAL INDUSTRIES LTD with 1 ClinicalTrials.gov record(s).

Program details

Company
TEVA PHARMACEUTICAL INDUSTRIES LTD
Indication
Bipolar I Depression
Phase
Phase 2
Modality
small_molecule
Status
completed

Clinical trials